
Recently, Mr. Joe Huntsman, the new CEO and owner of the Roanoke Area MS Center and Blue Ridge Neurology in Christiansburg was kind enough to answer some of the more common questions we have been hearing at the MS Alliance of Virginia regarding Dr. Jill Cramer’s retirement and subsequent purchase of her practice by BrookWell Infusion. Read below to hear what he has to say…
MSAV – When will the new neurologists and other providers be available to see patients, and how can appointments be scheduled?
Mr. Huntsman – The new neurology full team will begin to see patients in September and appointments are already being scheduled. However, we are providing infusions for several insurance plans this summer (already).
MSAV – What is the procedure for patients with existing referrals or those who have previously received care at the MS Center to return for appointments?
Mr. Huntsman – If a patient has received care at the Roanoke MS Center in Salem or Blue Ridge Associates in Neurology in Christiansburg in the past, we do not need a new referral unless insurance requires it. Simply a call to schedule an appointment is all that is needed. We truly hope that all patients return, and it would be an honor to serve each of them…….. Read more by clicking HERE!


New Website Offers Information for MS Caregivers
A new website aims to provide support to caregivers of people with multiple sclerosis (MS). The site, MS Care Partner Connection, brings together information on how caregivers can care for themselves while tending to those living with the disease, how to navigate the...
MS Bowel Problems: Ways To Manage Constipation and More
The symptoms of multiple sclerosis (MS) can vary from person to person and may change over time. But for nearly 70 percent of individuals with MS, symptoms include bowel problems like constipation, diarrhea, incontinence (loss of bowel control), and diverticulitis...
Long-Term Tecfidera Slows MS Disability Progression in Large Trial
Treatment with Tecfidera (dimethyl fumarate) significantly reduces relapse rates for people with multiple sclerosis (MS), and most MS patients on the approved therapy remain free from disability progression for several years. That’s according to a final analysis from...
IRX4204 Promotes Myelin Repair, Improves Gait in MS Mouse Model
IRX4204, a compound that Io Therapeutics is developing to treat neurological diseases, facilitated myelin repair and improved walking abilities in a mouse model of multiple sclerosis (MS) in a recent study, scientists report. “Our findings support the therapeutic...
MS Treatments Don’t Raise Miscarriage, Birth Defect Risk: Study
Most treatments for multiple sclerosis (MS) don’t increase the risk of major problems when used during pregnancy, an analysis showed. “We found that most therapies were not associated with an increased risk of miscarriage, premature birth or major birth defects,”...